Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shi-Wen Jiang
Preclinical Studies on Histone Deacetylase Inhibitors as Therapeutic Reagents for Endometrial and Ovarian Cancers
Future Oncology
Medicine
Cancer Research
Oncology
Related publications
Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies
Molecular Cancer Therapeutics
Cancer Research
Oncology
Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
Histone Deacetylase Inhibitors as Cancer Therapeutics
Annals of Translational Medicine
Medicine
Toward Isozyme-Selective Inhibitors of Histone Deacetylase as Therapeutic Agents for the Treatment of Cancer
Pharmaceutical patent analyst
Medicine
Drug Discovery
Pharmaceutical Science
Inhibitors of Histone-Deacetylase
Journal of Applied Biomedicine
Genetics
Molecular Biology
Pharmacology
Biochemistry
Biological Sciences
Toxicology
Medicine
Agricultural
Neuroscience
Pharmaceutics
Pharmacogenomics and Histone Deacetylase Inhibitors
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Development of Histone Deacetylase Inhibitors as Therapeutics for Neurological Disease
Future Neurology
Neurology
Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
Journal of Biomedicine and Biotechnology
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
Molecular Cancer Therapeutics
Cancer Research
Oncology